Health Care & Life Sciences » Pharmaceuticals » Top pharmaceutical drugs | Top Rx drugs by U.S. sales 2016

U.S. top 20 prescribed drugs based on sales 2016

Top 20 prescription drugs based on U.S. sales in 2016 (Figures expressed in billions of U.S. dollars, unless otherwise specified)

The data illustrates the U.S. top 20 prescription drugs based on total sales in 2016. In that year, Harvoni generated some 10 billion USD in sales. Thus, Harvoni was the second ranked drug in the U.S. based on revenue. Harvoni is manufactured by Gilead Sciences, a U.S. biotech company headquartered in Foster City, California.

Humira (AbbVie)	13.6
Harvoni (Gilead Sciences)	10
Enbrel (Amgen)	7.4
Lantus Solostar (Sanofi)	5.7
Remicade (J&J)	5.3
Januvia (Merck & Co.)	4.8
Advair Diskus (GSK)	4.7
Lyrica (Pfizer)	4.4
Crestor (AstraZeneca)	4.2
Neulasta (Amgen)	4.2
Copaxone (Teva)	4.1
Rituxan (Genentech)	3.9
Tecfidera (Biogen)	3.7
Xarelto (Janssen)	3.6
Lantus (Sanofi)	3.3
Eliquis (BMS/Pfizer)	3.2
Truvada (Gilead Sciences)	3.1
Vyvanse (Shire)	3.1
Avastin (Genentech)	3.1
Symbicort (AstraZeneca)	3

U.S. top 20 prescribed drugs based on sales 2016

StatInvestor